Velasco-Velázquez Marco Antonio, Agramonte-Hevia José, Barrera Diana, Jiménez-Orozco Alejandro, García-Mondragón María Juana, Mendoza-Patiño Nicandro, Landa Abraham, Mandoki Juan
Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Apdo. Postal 70-297, Ciudad Universitaria, México, DF 04510, Mexico.
Cancer Lett. 2003 Aug 20;198(2):179-86. doi: 10.1016/s0304-3835(03)00333-1.
This study determined the in vitro effects of 4-hydroxycoumarin (4-HC) employing the melanoma cell line B16-F10 and the non-malignant fibroblastic cell line B82. 4-HC disorganized the actin cytoskeleton in B16-F10 cells, but not in B82 fibroblasts. Cytoskeletal disorganization correlated with reductions in cell adhesion to four extracellular matrix proteins and inhibition of random motility. 4-HC did not modify cell viability or actin expression, but decreased tyrosine phosphorylation of several proteins in melanoma cells. Because adhesion of tumor cells to extracellular matrix is required during the metastatic process, 4-HC might be useful as an adjuvant therapy for melanoma.
本研究利用黑色素瘤细胞系B16-F10和非恶性成纤维细胞系B82,确定了4-羟基香豆素(4-HC)的体外作用。4-HC使B16-F10细胞中的肌动蛋白细胞骨架紊乱,但对B82成纤维细胞无此作用。细胞骨架紊乱与细胞对四种细胞外基质蛋白的粘附减少以及随机运动的抑制相关。4-HC未改变细胞活力或肌动蛋白表达,但降低了黑色素瘤细胞中几种蛋白质的酪氨酸磷酸化。由于肿瘤细胞在转移过程中需要与细胞外基质粘附,4-HC可能作为黑色素瘤的辅助治疗药物。